UBS Group AG - CYCLERION THERAPEUTICS INC ownership

CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 44 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CYCLERION THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$6,183
-48.6%
14,247
-21.8%
0.00%
Q4 2022$12,020
+200.5%
18,212
+399.6%
0.00%
Q1 2022$4,000
-63.6%
3,645
+2.8%
0.00%
Q3 2021$11,000
+1000.0%
3,544
+1212.6%
0.00%
Q2 2021$1,000
-92.3%
270
-94.2%
0.00%
Q1 2021$13,000
-23.5%
4,682
-13.6%
0.00%
Q4 2020$17,000
+750.0%
5,417
+1231.0%
0.00%
Q3 2020$2,000
-95.0%
407
-94.0%
0.00%
Q2 2020$40,000
+5.3%
6,780
-52.1%
0.00%
Q1 2020$38,000
-50.6%
14,162
-50.0%
0.00%
Q4 2019$77,000
-83.7%
28,319
-27.3%
0.00%
Q3 2019$471,000
+129.8%
38,949
+118.3%
0.00%
Q2 2019$205,00017,8420.00%
Other shareholders
CYCLERION THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Artal Group S.A. 552$20.00%
View complete list of CYCLERION THERAPEUTICS INC shareholders